Science Explorer Back to mapMap
Discussion
Researcher · Japan Tobacco (United States) · United States

Kiyoteru Ikegami

Kiyoteru Ikegami publishes mostly in Molecular Biology, Cardiology and Cardiovascular Medicine and Nutrition and Dietetics, on topics such as Receptor Mechanisms and Signaling, Phosphodiesterase function and regulation and Immune cells in cancer.

OpenAlex
World rank
#7,149,268
of 7,710,434 ranked researchers
Rank in United States
#1,587,285
of 1,627,098
Works
24
Citations
79
Citations per work
3.3
h-index
5
i10-index 1Top 97% in Molecular Biology
Kiyoteru Ikegami

What does Kiyoteru Ikegami research?

Kiyoteru Ikegami's work is mostly in Medicine (21%), Biochemistry, Genetics and Molecular Biology (21%), Nursing (6%).

Everything else: 11 works · 47.6% of their workHealth Sciences: 6 works · 27.0% of their workMedicine: 5 works · 20.7% of their workCardiology and Cardiovascular Medicine: 3 works · 12.7% of their workComplementary and alternative medicine: 1 works · 4.8% of their workEndocrinology, Diabetes and Metabolism: 1 works · 3.2% of their workNursing: 2 works · 6.3% of their workNutrition and Dietetics: 2 works · 6.3% of their workLife Sciences: 6 works · 25.4% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 20.6% of their workMolecular Biology: 5 works · 20.6% of their workImmunology and Microbiology: 1 works · 4.8% of their workImmunology: 1 works · 4.8% of their workTHEIR WORKKiyoteru Ikegami24works
Life Sciences25%Health Sciences27%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1147.6%
    1. Medicine520.7%
    2. Nursing26.3%
    1. Biochemistry, Genetics and Molecular Biology520.6%
    2. Immunology and Microbiology14.8%
  1. 1Molecular Biology21% of their works
  2. 2Cardiology and Cardiovascular Medicine13% of their works
  3. 3Nutrition and Dietetics6% of their works
  4. 4Immunology5% of their works
  5. 5Complementary and alternative medicine5% of their works
  6. 6Endocrinology, Diabetes and Metabolism3% of their works

Research topics

Which keywords describe Kiyoteru Ikegami's research?

The keywords of their largest research topics: cAMP Signaling, Cardiovascular Disease, Crystal Structure, Cyclic Nucleotide Phosphodiesterases, G-Protein-Coupled Receptors, Activation, Macrophage and Aldosterone.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Cardiovascular Disease42 topics
  2. Crystal Structure41 topic
  3. Cyclic Nucleotide Phosphodiesterases41 topic
  4. G-Protein-Coupled Receptors41 topic
  5. cAMP Signaling41 topic
  6. Activation31 topic
  7. Macrophage31 topic
  8. Aldosterone21 topic
  9. Arrhythmias21 topic
  10. Cardioprotection21 topic
  11. Guidelines21 topic
  12. Heart Failure21 topic
  13. Herbal Medicine21 topic
  14. Ischemia-Reperfusion Injury21 topic
  15. Long-QT Syndrome21 topic
  16. Primary Aldosteronism21 topic
  17. Traditional Chinese Medicine21 topic

Where does Kiyoteru Ikegami work?

Kiyoteru Ikegami's main affiliation in the publication record is Japan Tobacco (United States), United States.

How many publications and citations does Kiyoteru Ikegami have?

OpenAlex counts 24 works and 79 citations for Kiyoteru Ikegami, an h-index of 5, ranking #7,149,268 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kiyoteru Ikegami. Posts are plain text and can be reported.